Companies Privia Health Group
Privia Health (PRVA): executive pay, fiscal 2025
Free brief. Every figure links to the company’s own filing.
Velarion Intel: free for 3 days, no card →Email me Privia Health Group’s executive pay brief as a PDF
You get it on this page the moment you ask, and a copy by email. Every figure is cited to its filing.
After the PDF, up to three short notes on the deeper reports for this company. Reply “unsubscribe” to any of them, any time.
Compensation figures for fiscal year 2025 are temporarily unavailable — recheck shortly.
Executives and directors
Frequently asked questions
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Full detail
Every table from the filing. Open any section.
Summary compensation table
No Summary Compensation Table is on file for fiscal year 2025.
Equity grants and outstanding awards
Grants of plan-based awards — fiscal year 2025
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| Parth Mehrotra | RSU | 2025-03-05 | — | — | 133,723 | — | $3,435,344 |
| David Mountcastle | PSU | 2025-03-05 | 25,073 | 50,146 | — | 100,292 | 1,288,251 |
| Parth Mehrotra | PSU | 2025-03-05 | 100,293 | 200,585 | — | 401,170 | 5,153,029 |
| Edward C. Fargis | PSU | 2025-03-05 | 18,805 | 37,609 | — | 75,218 | 966,175 |
| David Mountcastle | RSU | 2025-03-05 | — | — | 33,430 | — | 858,817 |
| Edward C. Fargis | RSU | 2025-03-05 | — | — | 25,073 | — | 644,125 |
Vehicle mix — grant-date fair value by award type
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| Parth Mehrotra | $3,435,344 | $5,153,029 | $0 | 60.0% |
| David Mountcastle | 858,817 | 1,288,251 | 0 | 60.0% |
| Edward C. Fargis | 644,125 | 966,175 | 0 | 60.0% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
No outstanding equity awards are on file for this fiscal year.
Director compensation
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| David KingIndependent · Board Chair · Compensation · Nominating and Corporate Governance (Chair) | $145,000 | $199,825 | $0 | $0 | $0 | $344,825 |
| Thomas McCarthyIndependent · Audit (Chair) | 100,000 | 199,825 | 0 | 0 | 0 | 299,825 |
| Pamela KimmetIndependent · Compensation (Chair) · Nominating and Corporate Governance | 95,000 | 199,825 | 0 | 0 | 0 | 294,825 |
| Patricia MarylandIndependent · Compliance · Departed during FY | 77,083 | 199,825 | 0 | 0 | 0 | 276,908 |
| Jaewon RyuIndependent · Compliance (Chair) | 76,458 | 199,825 | 0 | 0 | — | 276,203 |
| Shawn MorrisNot independent · Compliance | 75,000 | 199,825 | 0 | 0 | 0 | 274,825 |
| David WichmannIndependent · Audit · Compensation · Not standing for re-election | 75,000 | 199,825 | 0 | 0 | 0 | 274,825 |
| Nancy CocozzaIndependent · Audit · Nominating and Corporate Governance | 75,000 | 199,825 | 0 | 0 | 0 | 274,825 |
| Lance BerberianIndependent · Audit · Compliance · Newly elected | 15,625 | 158,268 | 0 | 0 | 0 | 173,893 |
| Parth MehrotraEmployee director | 0 | 0 | 0 | — | 0 | 0 |
Board fee structure and ownership guideline
| Annual cash retainer | $75,000 |
|---|---|
| Annual equity retainer | $200,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 25,000 / 20,000 / 15,000 |
| Stock ownership guideline | $5 |
Total cost of the board
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $734,166 |
| Equity awards (grant-date value) | $1,756,868 |
| All other compensation | $0 |
| Total cost of the board | $2,491,034 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Peer group, and who names Privia Health as a peer
Companies that benchmark against PRVA
The list of companies that name PRVA as a peer is temporarily unavailable — recheck shortly.
Disclosed peer group — fiscal year 2025
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
Peer reciprocity
Of the companies Privia Health Group names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.
Reciprocity shown where the peer’s own current proxy has been read — each mark is cited in the register to that peer’s filing. A dash means the peer’s current proxy was read and names no reciprocal group including Privia Health Group.
Chief executive pay against the peer group
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company’s own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| — | Teladoc Health, Inc. | — | — | — | — | — | — | not in coverage universe |
| — | Claritev Corporation (f/k/a Multiplan Corporation) | — | — | — | — | — | — | not in coverage universe |
| — | Health Catalyst, Inc. | — | — | — | — | — | — | not in coverage universe |
| — | Surgery Partners, Inc. | — | — | — | — | — | — | not in coverage universe |
| — | Evolent Health, Inc. | — | — | — | — | — | — | not in coverage universe |
| — | Accolade, Inc. | — | — | — | — | — | — | not in coverage universe |
| — | Goodrx Holdings, Inc. | — | — | — | — | — | — | not in coverage universe |
| — | Phreesia, Inc. | — | — | — | — | — | — | not in coverage universe |
| — | Agilon Health, Inc. | — | — | — | — | — | — | not in coverage universe |
| — | Premier, Inc. | — | — | — | — | — | — | not in coverage universe |
| — | Alignment Healthcare, Inc. | — | — | — | — | — | — | not in coverage universe |
| — | Oscar Health, Inc. | — | — | — | — | — | — | not in coverage universe |
| — | Astrana Health, Inc. | — | — | — | — | — | — | not in coverage universe |
| — | Lifestance Health Group, Inc. | — | — | — | — | — | — | not in coverage universe |
Each peer’s compensation is from its most recently filed proxy; fiscal years differ by company. Each peer’s figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Incentive design against the same peers
| Company | Annual incentive payout | Long-term vehicle mix | PSU measures include TSR | Compensation consultant |
|---|---|---|---|---|
| Privia Health Group | not disclosed | not disclosed | not disclosed | not disclosed |
| Accolade, Inc. | not disclosed | not disclosed | not disclosed | not disclosed |
| Agilon Health, Inc. | not disclosed | not disclosed | not disclosed | not disclosed |
| Alignment Healthcare, Inc. | not disclosed | not disclosed | not disclosed | not disclosed |
| Astrana Health, Inc. | not disclosed | not disclosed | not disclosed | not disclosed |
| Claritev Corporation (f/k/a Multiplan Corporation) | not disclosed | not disclosed | not disclosed | not disclosed |
| Evolent Health, Inc. | not disclosed | not disclosed | not disclosed | not disclosed |
| Goodrx Holdings, Inc. | not disclosed | not disclosed | not disclosed | not disclosed |
| Health Catalyst, Inc. | not disclosed | not disclosed | not disclosed | not disclosed |
| Lifestance Health Group, Inc. | not disclosed | not disclosed | not disclosed | not disclosed |
| Oscar Health, Inc. | not disclosed | not disclosed | not disclosed | not disclosed |
| Phreesia, Inc. | not disclosed | not disclosed | not disclosed | not disclosed |
| Premier, Inc. | not disclosed | not disclosed | not disclosed | not disclosed |
| Surgery Partners, Inc. | not disclosed | not disclosed | not disclosed | not disclosed |
| Teladoc Health, Inc. | not disclosed | not disclosed | not disclosed | not disclosed |
Read from each company’s Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company’s filing does not state the item.
Say-on-pay history and pay ratio
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-05-20 | 103,956,500 | 1,813,934 | 105,446 | 98.29% | Passed |
| 2025 | 2025-05-21 | 105,145,830 | 1,431,629 | 41,566 | 98.66% | Passed |
| 2024 | 2024-05-22 | 96,616,303 | 26,663,618 | 4,660,430 | 78.37% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year’s compensation.
Say-on-pay — history, company’s computation
| Meeting year | Meeting date | Approval — company’s computation |
|---|---|---|
| 2026 | 2026-05-20 | 98.29%a |
| 2025 | 2025-05-21 | 98.66%b |
| 2024 | 2024-05-22 | 78.37%c |
a. Approved under the standard stated in the filing — “Abstentions and broker non-votes will have no effect on the outcome of this proposal.”.
b. Approved under the standard stated in the filing — “Abstentions and broker non-votes will have no effect on the outcome of this proposal.”.
c. Approved under the standard stated in the filing — “Abstentions and broker non-votes will have no effect on the outcome of this proposal.”.
Approval percentages are the company’s own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
CEO pay ratio
| Ratio (CEO : median employee) | 168 : 1 |
|---|---|
| CEO total compensation | $10,472,698 |
| Median employee compensation | $62,334 |
Insider trades since the proxy
No insider equity transactions reported since the proxy statement.
Sources (27 citations)
Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.
- Section 03, Parth Mehrotra RSU. DEF 14A, filed 2026-04-02. Section “EXECUTIVE COMPENSATION TABLES &” · grants of plan-based awards table. View filing ↗
- Section 03, David Mountcastle PSU. DEF 14A, filed 2026-04-02. Section “EXECUTIVE COMPENSATION TABLES &” · grants of plan-based awards table. View filing ↗
- Section 03, Parth Mehrotra PSU. DEF 14A, filed 2026-04-02. Section “EXECUTIVE COMPENSATION TABLES &” · grants of plan-based awards table. View filing ↗
- Section 03, Edward C. Fargis PSU. DEF 14A, filed 2026-04-02. Section “EXECUTIVE COMPENSATION TABLES &” · grants of plan-based awards table. View filing ↗
- Section 03, David Mountcastle RSU. DEF 14A, filed 2026-04-02. Section “EXECUTIVE COMPENSATION TABLES &” · grants of plan-based awards table. View filing ↗
- Section 03, Edward C. Fargis RSU. DEF 14A, filed 2026-04-02. Section “EXECUTIVE COMPENSATION TABLES &” · grants of plan-based awards table. View filing ↗
- Section 07, pay ratio. DEF 14A, filed 2026-04-02. Section “CEO Pay Ratio”. As printed: 168 : 1. View filing ↗
- Section 08, David King. DEF 14A, filed 2026-04-02. Section “Director Compensation”. As printed: 344,825. View filing ↗
- Section 08, Thomas McCarthy. DEF 14A, filed 2026-04-02. Section “Director Compensation”. As printed: 299,825. View filing ↗
- Section 08, Pamela Kimmet. DEF 14A, filed 2026-04-02. Section “Director Compensation”. As printed: 294,825. View filing ↗
- Section 08, Patricia Maryland. DEF 14A, filed 2026-04-02. Section “Director Compensation”. As printed: 276,908. View filing ↗
- Section 08, Jaewon Ryu. DEF 14A, filed 2026-04-02. Section “Director Compensation”. As printed: 276,203. View filing ↗
- Section 08, Shawn Morris. DEF 14A, filed 2026-04-02. Section “Director Compensation”. As printed: 274,825. View filing ↗
- Section 08, David Wichmann. DEF 14A, filed 2026-04-02. Section “Director Compensation”. As printed: 274,825. View filing ↗
- Section 08, Nancy Cocozza. DEF 14A, filed 2026-04-02. Section “Director Compensation”. As printed: 274,825. View filing ↗
- Section 08, Lance Berberian. DEF 14A, filed 2026-04-02. Section “Director Compensation”. As printed: 173,893. View filing ↗
- Section 08, Parth Mehrotra. DEF 14A, filed 2026-04-02. Section “Director Compensation”. As printed: 0. View filing ↗
- Section 06, 2026 vote. Form 8-K, filed 2026-05-22. Item 5.07 · say-on-pay result. As reported: 98.29% (votes for as printed: 103,956,500). View filing ↗
- Section 06, 2025 vote. Form 8-K, filed 2025-05-22. Item 5.07 · say-on-pay result. As reported: 98.66% (votes for as printed: 105,145,830). View filing ↗
- Section 06, 2024 vote. Form 8-K, filed 2024-05-23. Item 5.07 · say-on-pay result. As reported: 78.37% (votes for as printed: 96,616,303). View filing ↗
- Section 03b vehicle mix (computed). Computed. RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).
- Section 09b board cost (computed). Computed. Cash 734,166 + equity 1,756,868 + all other 0 = 2,491,034, summed across the director compensation table rows.
- Section 10a, Teladoc Health, Inc. reciprocity. DEF 14A. Teladoc Health, Inc. names Privia Health Group in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Claritev Corporation (f/k/a Multiplan Corporation) reciprocity. DEF 14A. Claritev Corporation (f/k/a Multiplan Corporation)'s most recent proxy was read; its disclosed peer group does not include Privia Health Group. View filing ↗
- Section 10a, Health Catalyst, Inc. reciprocity. DEF 14A. Health Catalyst, Inc.'s most recent proxy was read; its disclosed peer group does not include Privia Health Group. View filing ↗
- Section 10a, Surgery Partners, Inc. reciprocity. DEF 14A. Surgery Partners, Inc.'s most recent proxy was read; its disclosed peer group does not include Privia Health Group. View filing ↗
- Section 10a, Evolent Health, Inc. reciprocity. DEF 14A. Evolent Health, Inc.'s most recent proxy was read; its disclosed peer group does not include Privia Health Group. View filing ↗